{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:18:10Z","timestamp":1787897890468,"version":"build-2784847793"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88840-5","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T18:02:01Z","timestamp":1738605721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MiR-25-3p regulates pulmonary arteriovenous malformation after Glenn procedure in patients with univentricular heart via the PHLPP2-HIF-1\u03b1 axis"],"prefix":"10.1038","volume":"15","author":[{"given":"Junpei","family":"Kawamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munekazu","family":"Yamakuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruto","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"88840_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0022-5223(19)40598-9","volume":"66","author":"G Kreutzer","year":"1973","unstructured":"Kreutzer, G., Gal\u00edndez, E., Bono, H., De Palma, C. & Laura, J. P. An operation for the correction of tricuspid atresia. J. Thorac. Cardiovasc. Surg. 66, 613\u2013621 (1973).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"88840_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijcard.2016.05.035","volume":"219","author":"C Schilling","year":"2016","unstructured":"Schilling, C. et al. The Fontan epidemic: Population projections from the Australia and New Zealand Fontan Registry. Int. J. Cardiol. 219, 14\u201319 (2016).","journal-title":"Int. J. Cardiol."},{"key":"88840_CR3","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/S0003-4975(00)02164-0","volume":"70","author":"SJ Kim","year":"2000","unstructured":"Kim, S. J. et al. Development of pulmonary arteriovenous fistulas after bidirectional cavopulmonary shunt. Ann. Thorac. Surg. 70, 1918\u20131922 (2000).","journal-title":"Ann. Thorac. Surg."},{"key":"88840_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/01.CIR.55.1.212","volume":"55","author":"RC McFaul","year":"1977","unstructured":"McFaul, R. C., Tajik, A. J., Mair, D. D., Danielson, G. K. & Seward, J. B. Development of pulmonary arteriovenous shunt after superior vena cava-right pulmonary artery (Glenn) anastomosis. Circulation 55, 212\u2013216 (1977). Report of four cases.","journal-title":"Circulation"},{"key":"88840_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.tcb.2010.06.006","volume":"20","author":"E Pardali","year":"2010","unstructured":"Pardali, E., Goumans, M. J. & ten Dijke, P. Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell. Biol. 20, 556\u2013567 (2010).","journal-title":"Trends Cell. Biol."},{"key":"88840_CR6","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/00006123-200010000-00022","volume":"47","author":"T Hashimoto","year":"2000","unstructured":"Hashimoto, T. et al. Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Neurosurgery 47, 910\u2013919 (2000).","journal-title":"Neurosurgery"},{"key":"88840_CR7","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3171\/jns.2001.94.6.0972","volume":"94","author":"N Butz","year":"2001","unstructured":"Butz, N. et al. Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J. Neurosurg. 94, 972\u2013977 (2001).","journal-title":"J. Neurosurg."},{"key":"88840_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2174\/1573403X13666170510115628","volume":"13","author":"JJ Vettukattil","year":"2017","unstructured":"Vettukattil, J. J. Is the hepatic factor a miRNA that maintains the integrity of pulmonary microvasculature by inhibiting the vascular endothelial growth factor? Curr. Cardiol. Rev. 13, 244\u2013250 (2017).","journal-title":"Curr. Cardiol. Rev."},{"key":"88840_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yexcr.2018.02.009","volume":"365","author":"C Yang","year":"2018","unstructured":"Yang, C. et al. miR144-3p inhibits PMVECs excessive proliferation in angiogenesis of hepatopulmonary syndrome via Tie2. Exp. Cell. Res. 365, 24\u201332 (2018).","journal-title":"Exp. Cell. Res."},{"key":"88840_CR10","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41419-019-2087-y","volume":"10","author":"L Chen","year":"2019","unstructured":"Chen, L. et al. Hepatocyte-derived exosomal MiR-194 activates PMVECs and promotes angiogenesis in hepatopulmonary syndrome. Cell. Death Dis. 10, 853 (2019).","journal-title":"Cell. Death Dis."},{"key":"88840_CR11","doi-asserted-by":"publisher","first-page":"bio044800","DOI":"10.1242\/bio.044800","volume":"8","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. MiR145-5p inhibits proliferation of PMVECs via PAI-1 in experimental hepatopulmonary syndrome rat pulmonary microvascular hyperplasia. Biol. Open. 8, bio044800 (2019).","journal-title":"Biol. Open."},{"key":"88840_CR12","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1161\/CIRCRESAHA.119.316317","volume":"127","author":"NI Mar\u00edn-Ramos","year":"2020","unstructured":"Mar\u00edn-Ramos, N. I. et al. miR-18a inhibits BMP4 and HIF-1\u03b1 normalizing brain arteriovenous malformations. Circ. Res. 127, e210\u2013e231 (2020).","journal-title":"Circ. Res."},{"key":"88840_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/STROKEAHA.113.003578","volume":"45","author":"R Ferreira","year":"2014","unstructured":"Ferreira, R. et al. MicroRNA-18a improves human cerebral arteriovenous malformation endothelial cell function. Stroke 45, 293\u2013297 (2014).","journal-title":"Stroke"},{"key":"88840_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10456-013-9362-9","volume":"16","author":"SP Tabruyn","year":"2013","unstructured":"Tabruyn, S. P. et al. MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells. Angiogenesis 16, 877\u2013887 (2013).","journal-title":"Angiogenesis"},{"key":"88840_CR15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/cells10061373","volume":"10","author":"IA Florian","year":"2021","unstructured":"Florian, I. A. et al. An insight into the microRNAs associated with arteriovenous and cavernous malformations of the brain. Cells 10, 1373 (2021).","journal-title":"Cells"},{"key":"88840_CR16","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/brainsci12121628","volume":"12","author":"A Giotta Lucifero","year":"2022","unstructured":"Giotta Lucifero, A. & Luzzi, S. Brain AVMs-related microRNAs: machine learning algorithm for expression profiles of target genes. Brain Sci. 12, 1628 (2022).","journal-title":"Brain Sci."},{"key":"88840_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/STROKEAHA.121.035654","volume":"53","author":"V Venugopal","year":"2022","unstructured":"Venugopal, V. & Sumi, S. Molecular biomarkers and drug targets in brain arteriovenous and cavernous malformations. Where are we? Stroke 53, 279\u2013289 (2022).","journal-title":"Stroke"},{"key":"88840_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/ana.25015","volume":"82","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. MicroRNA-137 and microRNA-195* inhibit vasculogenesis in brain arteriovenous malformations. Ann. Neurol. 82, 371\u2013384 (2017).","journal-title":"Ann. Neurol."},{"key":"88840_CR19","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.ymthe.2019.06.011","volume":"27","author":"S Kilari","year":"2019","unstructured":"Kilari, S. et al. The role of MicroRNA-21 in venous neointimal hyperplasia: Implications for targeting miR-21 for VNH treatment. Mol. Ther. 27, 1681\u20131693 (2019).","journal-title":"Mol. Ther."},{"key":"88840_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/ejechocard\/jen317","volume":"10","author":"P Gazzaniga","year":"2009","unstructured":"Gazzaniga, P. et al. Contrast echocardiography for pulmonary arteriovenous malformations screening: Does any bubble matter? Eur. J. Echocardiogr. 10, 513\u2013518 (2009).","journal-title":"Eur. J. Echocardiogr"},{"key":"88840_CR21","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/s41467-019-09712-x","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Excessive mir-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression. Nat. Commun. 10, 1858 (2019).","journal-title":"Nat. Commun."},{"key":"88840_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nature13073","volume":"508","author":"C Wahlquist","year":"2014","unstructured":"Wahlquist, C. et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature 508, 531\u2013535 (2014).","journal-title":"Nature"},{"key":"88840_CR23","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ymthe.2017.11.014","volume":"26","author":"D Jeong","year":"2018","unstructured":"Jeong, D. et al. miR-25 tough decoy enhances cardiac function in heart failure. Mol. Ther. 26, 718\u2013729 (2018).","journal-title":"Mol. Ther."},{"key":"88840_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1164\/rccm.201604-0814OC","volume":"195","author":"Z Hong","year":"2017","unstructured":"Hong, Z. et al. MicroRNA-138 and MicroRNA-25 down-regulate mitochondrial calcium uniporter, causing the pulmonary arterial hypertension cancer phenotype. Am. J. Respir Crit. Care Med. 195, 515\u2013529 (2017).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"88840_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/21655979.2019.1710924","volume":"11","author":"L Ning","year":"2020","unstructured":"Ning, L. et al. Mir-25-3p inhibition impairs tumorigenesis and invasion in gastric cancer cells in vitro and in vivo. Bioengineered 11, 81\u201390 (2020).","journal-title":"Bioengineered"},{"key":"88840_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12943-017-0754-0","volume":"17","author":"H Chen","year":"2018","unstructured":"Chen, H., Pan, H., Qian, Y., Zhou, W. & Liu, X. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2. Mol. Cancer 17, 4 (2018).","journal-title":"Mol. Cancer"},{"key":"88840_CR27","doi-asserted-by":"publisher","first-page":"BSR20201901","DOI":"10.1042\/BSR20201901","volume":"40","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. MiR-25-3p targets PTEN to regulate the migration, invasion, and apoptosis of esophageal cancer cells via the PI3K\/AKT pathway. Biosci. Rep. 40, BSR20201901 (2020).","journal-title":"Biosci. Rep."},{"key":"88840_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3892\/ijo.2021.5244","volume":"59","author":"J Wang","year":"2021","unstructured":"Wang, J., Li, T. & Wang, B. Exosomal transfer of miR-25-3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7. Int. J. Oncol. 59, 64 (2021).","journal-title":"Int. J. Oncol."},{"key":"88840_CR29","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1038\/s41467-018-07810-w","volume":"9","author":"Z Zeng","year":"2018","unstructured":"Zeng, Z. et al. Cancer-derived exosomal mir-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat. Commun. 9, 5395 (2018).","journal-title":"Nat. Commun."},{"key":"88840_CR30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fcimb.2019.00366","volume":"9","author":"N Li","year":"2019","unstructured":"Li, N. et al. Exosome-transmitted miR-25 Induced by H. Pylori promotes vascular endothelial cell Injury by targeting KLF2. Front. Cell. Infect. Microbiol. 9, 366 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"88840_CR31","first-page":"22599","volume":"12","author":"C Lian","year":"2020","unstructured":"Lian, C. et al. Mir-25-3p promotes endothelial cell angiogenesis in aging mice via TULA-2\/SYK\/VEGFR-2 downregulation. Aging (Albany NY) 12, 22599\u201322613 (2020).","journal-title":"Aging (Albany NY)"},{"key":"88840_CR32","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.2147\/JIR.S347754","volume":"15","author":"S Li","year":"2022","unstructured":"Li, S. et al. The Transcriptional landscapes and key genes in brain arteriovenous malformation progression in a venous hypertension rat model revealed by RNA sequencing. J. Inflamm. Res. 15, 1381\u20131397 (2022).","journal-title":"J. Inflamm. Res."},{"key":"88840_CR33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1146\/annurev-pharmtox-011112-140338","volume":"54","author":"AC Newton","year":"2014","unstructured":"Newton, A. C. & Trotman, L. C. Turning off AKT: PHLPP as a drug target. Annu. Rev. Pharmacol. Toxicol. 54, 537\u2013558 (2014).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"88840_CR34","doi-asserted-by":"publisher","first-page":"6510","DOI":"10.1074\/jbc.M110.183087","volume":"286","author":"J Liu","year":"2011","unstructured":"Liu, J., Stevens, P. D. & Gao, T. mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells. J. Biol. Chem. 286, 6510\u20136520 (2011).","journal-title":"J. Biol. Chem."},{"key":"88840_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tox.2019.03.006","volume":"419","author":"L Gu","year":"2019","unstructured":"Gu, L. et al. Arecoline suppresses epithelial cell viability through the Akt\/mTOR signaling pathway via upregulation of PHLPP2. Toxicology 419, 32\u201339 (2019).","journal-title":"Toxicology"},{"key":"88840_CR36","doi-asserted-by":"publisher","first-page":"10255","DOI":"10.1038\/ncomms10255","volume":"7","author":"K Kim","year":"2016","unstructured":"Kim, K. et al. mTORC1-independent raptor prevents hepatic steatosis by stabilizing PHLPP2. Nat. Commun. 7, 10255 (2016).","journal-title":"Nat. Commun."},{"key":"88840_CR37","doi-asserted-by":"publisher","first-page":"696802","DOI":"10.3389\/fphar.2021.696802","volume":"12","author":"X Ba","year":"2021","unstructured":"Ba, X. et al. WTD attenuating rheumatoid arthritis via suppressing angiogenesis and modulating the PI3K\/AKT\/mTOR\/HIF-1\u03b1 pathway. Front. Pharmacol. 12, 696802 (2021).","journal-title":"Front. Pharmacol."},{"key":"88840_CR38","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/onc.2014.164","volume":"34","author":"KM Dodd","year":"2015","unstructured":"Dodd, K. M., Yang, J., Shen, M. H., Sampson, J. R. & Tee, A. R. mTORC1 drives HIF-1\u03b1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene 34, 2239\u20132250 (2015).","journal-title":"Oncogene"},{"key":"88840_CR39","doi-asserted-by":"publisher","first-page":"20534","DOI":"10.1074\/jbc.M611782200","volume":"282","author":"SC Land","year":"2007","unstructured":"Land, S. C. & Tee, A. R. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J. Biol. Chem. 282, 20534\u201320543 (2007).","journal-title":"J. Biol. Chem."},{"key":"88840_CR40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/nature05029","volume":"442","author":"R Bernardi","year":"2006","unstructured":"Bernardi, R. et al. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature 442, 779\u2013785 (2006).","journal-title":"Nature"},{"key":"88840_CR41","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.ccell.2015.10.004","volume":"28","author":"S Sun","year":"2015","unstructured":"Sun, S. et al. Constitutive activation of mTORC1 in endothelial cells leads to the development and progression of lymphangiosarcoma through VEGF autocrine signaling. Cancer Cell. 28, 758\u2013772 (2015).","journal-title":"Cancer Cell."},{"key":"88840_CR42","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1128\/MCB.00695-13","volume":"33","author":"YA Wen","year":"2013","unstructured":"Wen, Y. A., Stevens, P. D., Gasser, M. L., Andrei, R. & Gao, T. Downregulation of PHLPP expression contributes to hypoxia-induced resistance to chemotherapy in colon cancer cells. Mol. Cell. Biol. 33, 4594\u20134605 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"88840_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12079-016-0352-8","volume":"10","author":"CS Abhinand","year":"2016","unstructured":"Abhinand, C. S., Raju, R., Soumya, S. J., Arya, P. S. & Sudhakaran, P. R. VEGF-A\/VEGFR2 signaling network in endothelial cells relevant to angiogenesis. J. Cell. Commun. Signal. 10, 347\u2013354 (2016).","journal-title":"J. Cell. Commun. Signal."},{"key":"88840_CR44","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1016\/j.bbagen.2018.08.013","volume":"1862","author":"A Sadremomtaz","year":"2018","unstructured":"Sadremomtaz, A. et al. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K\/AKT and MAPK\/ERK1\/2 pathway. Biochim. Biophys. Acta Gen. Subj. 1862, 2688\u20132700 (2018).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"88840_CR45","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1074\/jbc.M111.293985","volume":"287","author":"E Guangqi","year":"2012","unstructured":"Guangqi, E. et al. Endogenous vascular endothelial growth factor-A (VEGF-A) maintains endothelial cell homeostasis by regulating VEGF receptor-2 transcription. J. Biol. Chem. 287, 3029\u20133041 (2012).","journal-title":"J. Biol. Chem."},{"key":"88840_CR46","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1159\/000465389","volume":"41","author":"L Ju","year":"2017","unstructured":"Ju, L., Zhou, Z., Jiang, B., Lou, Y. & Guo, X. Autocrine VEGF and IL-8 promote migration via Src\/Vav2\/Rac1\/PAK1 signaling in human umbilical vein endothelial cells. Cell. Physiol. Biochem. 41, 1346\u20131359 (2017).","journal-title":"Cell. Physiol. Biochem."},{"key":"88840_CR47","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1073\/pnas.0804543106","volume":"106","author":"K Al-Nedawi","year":"2009","unstructured":"Al-Nedawi, K., Meehan, B., Kerbel, R. S., Allison, A. C. & Rak, J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc. Natl. Acad. Sci. U S A. 106, 3794\u20133799 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"88840_CR48","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cell.2007.06.054","volume":"130","author":"S Lee","year":"2007","unstructured":"Lee, S. et al. Autocrine VEGF signaling is required for vascular homeostasis. Cell 130, 691\u2013703 (2007).","journal-title":"Cell"},{"key":"88840_CR49","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1161\/ATVBAHA.120.314172","volume":"40","author":"J Huang","year":"2020","unstructured":"Huang, J. et al. Endothelial scaffolding protein ENH (Enigma Homolog protein) promotes PHLPP2 (pleckstrin homology domain and leucine-rich repeat protein phosphatase 2)-mediated dephosphorylation of AKT1 and eNOS (endothelial NO synthase) promoting vascular remodeling. Arterioscler. Thromb. Vasc Biol. 40, 1705\u20131721 (2020).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"88840_CR50","doi-asserted-by":"publisher","first-page":"110060","DOI":"10.1016\/j.intimp.2023.110060","volume":"119","author":"L Liu","year":"2023","unstructured":"Liu, L. et al. Hepatocyte-derived extracellular vesicles mir-122-5p promotes hepatic ischemia reperfusion injury by regulating Kupffer cell polarization. Int. Immunopharmacol. 119, 110060 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"88840_CR51","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1136\/gutjnl-2015-310822","volume":"65","author":"N Calo","year":"2016","unstructured":"Calo, N. et al. Stress-activated miR-21\/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption. Gut 65, 1871\u20131881 (2016).","journal-title":"Gut"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88840-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88840-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88840-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T18:02:04Z","timestamp":1738605724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88840-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88840"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88840-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4138"}}